It is primarily investigated for its potential in antiviral therapies, particularly in targeting HIV. The compound has shown promise in inhibiting viral replication by interfering with the function of the viral Tat protein, which is crucial for the transcription of the HIV genome. This mechanism makes it a candidate for developing treatments aimed at reducing viral load in infected individuals. Additionally, its application extends to research settings, where it is used to study the molecular biology of HIV and to explore new therapeutic strategies for managing the infection.